Cargando…
S211: EFFICACY AND SAFETY OF ROPEGINTERFERON ALFA-2B FOR PRE-FIBROTIC PRIMARY MYELOFIBROSIS AND DIPSS LOW/INTERMEDIATE-1 RISK MYELOFIBROSIS: UPDATED RESULTS AND GENOMIC CHARACTERISTICS
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428496/ http://dx.doi.org/10.1097/01.HS9.0000967756.92473.72 |
| _version_ | 1785090484029358080 |
|---|---|
| author | Gill, Harry Au, Lester Tsai, Dorothy Leung, Man Kit Garret Yim, Rita Chin, Lynn LI, Vivian Lee, Paul Sin, Chung Fung Albert Hou, Hsin-An Chen, Chih-Cheng Kwong, Yok Lam |
| author_facet | Gill, Harry Au, Lester Tsai, Dorothy Leung, Man Kit Garret Yim, Rita Chin, Lynn LI, Vivian Lee, Paul Sin, Chung Fung Albert Hou, Hsin-An Chen, Chih-Cheng Kwong, Yok Lam |
| author_sort | Gill, Harry |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428496 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104284962023-08-17 S211: EFFICACY AND SAFETY OF ROPEGINTERFERON ALFA-2B FOR PRE-FIBROTIC PRIMARY MYELOFIBROSIS AND DIPSS LOW/INTERMEDIATE-1 RISK MYELOFIBROSIS: UPDATED RESULTS AND GENOMIC CHARACTERISTICS Gill, Harry Au, Lester Tsai, Dorothy Leung, Man Kit Garret Yim, Rita Chin, Lynn LI, Vivian Lee, Paul Sin, Chung Fung Albert Hou, Hsin-An Chen, Chih-Cheng Kwong, Yok Lam Hemasphere Oral Sessions Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428496/ http://dx.doi.org/10.1097/01.HS9.0000967756.92473.72 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Oral Sessions Gill, Harry Au, Lester Tsai, Dorothy Leung, Man Kit Garret Yim, Rita Chin, Lynn LI, Vivian Lee, Paul Sin, Chung Fung Albert Hou, Hsin-An Chen, Chih-Cheng Kwong, Yok Lam S211: EFFICACY AND SAFETY OF ROPEGINTERFERON ALFA-2B FOR PRE-FIBROTIC PRIMARY MYELOFIBROSIS AND DIPSS LOW/INTERMEDIATE-1 RISK MYELOFIBROSIS: UPDATED RESULTS AND GENOMIC CHARACTERISTICS |
| title | S211: EFFICACY AND SAFETY OF ROPEGINTERFERON ALFA-2B FOR PRE-FIBROTIC PRIMARY MYELOFIBROSIS AND DIPSS LOW/INTERMEDIATE-1 RISK MYELOFIBROSIS: UPDATED RESULTS AND GENOMIC CHARACTERISTICS |
| title_full | S211: EFFICACY AND SAFETY OF ROPEGINTERFERON ALFA-2B FOR PRE-FIBROTIC PRIMARY MYELOFIBROSIS AND DIPSS LOW/INTERMEDIATE-1 RISK MYELOFIBROSIS: UPDATED RESULTS AND GENOMIC CHARACTERISTICS |
| title_fullStr | S211: EFFICACY AND SAFETY OF ROPEGINTERFERON ALFA-2B FOR PRE-FIBROTIC PRIMARY MYELOFIBROSIS AND DIPSS LOW/INTERMEDIATE-1 RISK MYELOFIBROSIS: UPDATED RESULTS AND GENOMIC CHARACTERISTICS |
| title_full_unstemmed | S211: EFFICACY AND SAFETY OF ROPEGINTERFERON ALFA-2B FOR PRE-FIBROTIC PRIMARY MYELOFIBROSIS AND DIPSS LOW/INTERMEDIATE-1 RISK MYELOFIBROSIS: UPDATED RESULTS AND GENOMIC CHARACTERISTICS |
| title_short | S211: EFFICACY AND SAFETY OF ROPEGINTERFERON ALFA-2B FOR PRE-FIBROTIC PRIMARY MYELOFIBROSIS AND DIPSS LOW/INTERMEDIATE-1 RISK MYELOFIBROSIS: UPDATED RESULTS AND GENOMIC CHARACTERISTICS |
| title_sort | s211: efficacy and safety of ropeginterferon alfa-2b for pre-fibrotic primary myelofibrosis and dipss low/intermediate-1 risk myelofibrosis: updated results and genomic characteristics |
| topic | Oral Sessions |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428496/ http://dx.doi.org/10.1097/01.HS9.0000967756.92473.72 |
| work_keys_str_mv | AT gillharry s211efficacyandsafetyofropeginterferonalfa2bforprefibroticprimarymyelofibrosisanddipsslowintermediate1riskmyelofibrosisupdatedresultsandgenomiccharacteristics AT aulester s211efficacyandsafetyofropeginterferonalfa2bforprefibroticprimarymyelofibrosisanddipsslowintermediate1riskmyelofibrosisupdatedresultsandgenomiccharacteristics AT tsaidorothy s211efficacyandsafetyofropeginterferonalfa2bforprefibroticprimarymyelofibrosisanddipsslowintermediate1riskmyelofibrosisupdatedresultsandgenomiccharacteristics AT leungmankitgarret s211efficacyandsafetyofropeginterferonalfa2bforprefibroticprimarymyelofibrosisanddipsslowintermediate1riskmyelofibrosisupdatedresultsandgenomiccharacteristics AT yimrita s211efficacyandsafetyofropeginterferonalfa2bforprefibroticprimarymyelofibrosisanddipsslowintermediate1riskmyelofibrosisupdatedresultsandgenomiccharacteristics AT chinlynn s211efficacyandsafetyofropeginterferonalfa2bforprefibroticprimarymyelofibrosisanddipsslowintermediate1riskmyelofibrosisupdatedresultsandgenomiccharacteristics AT livivian s211efficacyandsafetyofropeginterferonalfa2bforprefibroticprimarymyelofibrosisanddipsslowintermediate1riskmyelofibrosisupdatedresultsandgenomiccharacteristics AT leepaul s211efficacyandsafetyofropeginterferonalfa2bforprefibroticprimarymyelofibrosisanddipsslowintermediate1riskmyelofibrosisupdatedresultsandgenomiccharacteristics AT sinchungfungalbert s211efficacyandsafetyofropeginterferonalfa2bforprefibroticprimarymyelofibrosisanddipsslowintermediate1riskmyelofibrosisupdatedresultsandgenomiccharacteristics AT houhsinan s211efficacyandsafetyofropeginterferonalfa2bforprefibroticprimarymyelofibrosisanddipsslowintermediate1riskmyelofibrosisupdatedresultsandgenomiccharacteristics AT chenchihcheng s211efficacyandsafetyofropeginterferonalfa2bforprefibroticprimarymyelofibrosisanddipsslowintermediate1riskmyelofibrosisupdatedresultsandgenomiccharacteristics AT kwongyoklam s211efficacyandsafetyofropeginterferonalfa2bforprefibroticprimarymyelofibrosisanddipsslowintermediate1riskmyelofibrosisupdatedresultsandgenomiccharacteristics |